title: Chronic Hepatitis B, C, and D.
abstract: Chronic hepatitis B, C, and D virus infections contribute significantly to the morbidity and mortality of immunocompromised individuals. To contextualize discussion of these infections in immunocompromised patients, this paper provides an overview of aspects of infection in normal hosts. It then describes differences in disease, diagnostic testing, and therapeutic management observed in immunocompromised patients.
authors.affiliation: Roche Diagnostics Corporation, Indianapolis, IN 46250.
authors.forename: Bryan R
authors.initials: BR
authors.lastname: Cobb
authors.affiliation: Johns Hopkins Hospital, Baltimore, MD 21287.
authors.forename: Alexandra
authors.initials: A
authors.lastname: Valsamakis
mesh_terms: D019694:Hepatitis B, Chronic / Q000175:diagnosis* / Q000473:pathology / Q000628:therapy*; D019698:Hepatitis C, Chronic / Q000175:diagnosis* / Q000473:pathology / Q000628:therapy*; D019701:Hepatitis D, Chronic / Q000175:diagnosis* / Q000473:pathology / Q000628:therapy*; D006801:Humans; D016867:Immunocompromised Host